NCT00136539 Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer Status COMPLETED Phase PHASE2
NCT00135447 A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen Status COMPLETED Phase N/A
NCT00135434 Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism Status COMPLETED Phase PHASE1
NCT00135421 Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder Status COMPLETED Phase PHASE1/PHASE2
NCT00135408 A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide Status COMPLETED Phase PHASE2
NCT00135395 A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen Status COMPLETED Phase PHASE3
NCT00135382 Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen Status COMPLETED Phase PHASE3
NCT00135369 Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen Status COMPLETED Phase PHASE3
NCT00135356 Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome Status COMPLETED Phase PHASE4
NCT00135343 A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen Status COMPLETED Phase PHASE3
NCT00134706 A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00130806 An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065) Status TERMINATED Phase PHASE3
NCT00130689 Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer Status COMPLETED Phase PHASE2
NCT00129922 Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer Status COMPLETED Phase PHASE3
NCT00129389 FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients Status COMPLETED Phase PHASE3
NCT00128856 Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients Status COMPLETED Phase PHASE2
NCT00126308 Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy Status TERMINATED Phase PHASE4
NCT00125645 Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study) Status COMPLETED Phase PHASE4
NCT00124982 Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy Status COMPLETED Phase PHASE3
NCT00124449 Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients Status COMPLETED Phase PHASE2